Related Experiment Video
Updated: Jan 9, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
Changes in Prescription Patterns and Diagnostic Outcomes of Polysomnography After Insurance Coverage: A Multicenter
Do-Yang Park1, Jae Hoon Cho2, Chan-Soon Park3
1Department of Otorhinolaryngology-Head and Neck Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.
South Korea
Area of Science:
- Sleep Medicine
- Health Policy Analysis
- Diagnostic Access
Background:
- South Korea expanded insurance coverage for polysomnography (PSG) in June 2018 to improve obstructive sleep apnea (OSA) diagnosis.
- This policy aimed to increase diagnostic accessibility for OSA patients.
Purpose of the Study:
- To investigate the impact of expanded insurance coverage on PSG utilization and diagnostic outcomes for OSA.
- To analyze changes in patient demographics and apnea-hypopnea index (AHI) distributions post-policy implementation.
Main Methods:
- A multicenter retrospective study analyzed data from 17 tertiary hospitals in South Korea.
- Included patients (≥20 years) suspected of OSA from 2015-2023, comparing pre-coverage (2015-2017) and post-coverage (2019-2023) periods.
- Compared demographics, PSG rates, and AHI distributions between the two periods.
Main Results:
- PSG utilization increased significantly from 51.3% to 74.4% (p<0.001).
- The proportion of female patients and mean age increased, indicating broader access.
- Average AHI rose, with a significant increase in severe OSA diagnoses (AHI ≥30) and a decrease in normal AHI cases (p<0.001).
Conclusions:
- Expanded insurance coverage improved PSG accessibility, especially for older adults, women, and high-risk individuals.
- The shift towards more severe OSA diagnoses suggests better detection of untreated cases.
- Findings support inclusive health policies while highlighting the need for appropriate patient selection for OSA diagnosis.
More Related Videos
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Blind Procedures
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Narcolepsy
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...